News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen Class of 2024
Insights
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Jobs
Career Advice
Companies
Hotbeds
More
Employer Resources
Best Places to Work
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen Class of 2024
Insights
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Jobs
Career Advice
Companies
Hotbeds
More
Employer Resources
Best Places to Work
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
619,265 Results
Type
Article (51443)
Company Profile (174)
Press Release (567648)
Section
Business (178635)
Career Advice (2683)
Deals (32949)
Drug Delivery (93)
Drug Development (78425)
Employer Resources (162)
FDA (16268)
Job Trends (15143)
News (315001)
Policy (32201)
Tag
Academia (2816)
Africa (919)
Alliances (45939)
Alzheimer's disease (1187)
Antibody-drug conjugate (ADC) (64)
Approvals (16173)
Arizona (118)
Artificial intelligence (75)
Asia (36962)
Australia (6364)
Bankruptcy (329)
Best Places to Work (11242)
Biosimilars (70)
Biotechnology (125)
C2C Services and Suppliers (68039)
California (1849)
Canada (788)
Cancer (540)
Career advice (2256)
Cell therapy (137)
China (145)
Clinical research (61624)
Collaboration (151)
Colorado (83)
Connecticut (65)
COVID-19 (2722)
Cystic fibrosis (78)
Data (320)
Diabetes (86)
Diagnostics (6036)
Drug pricing (76)
Earnings (64613)
Employer resources (142)
Europe (84703)
Events (82206)
Executive appointments (157)
FDA (16495)
Florida (247)
Funding (145)
Gene therapy (103)
GLP-1 (594)
Government (4602)
Healthcare (18584)
Hotbed/Location (410769)
Illinois (249)
Indiana (145)
Infectious disease (2756)
Inflammatory bowel disease (96)
Interviews (502)
IPO (14455)
Job creations (4020)
Job search strategy (1901)
Kansas (87)
Layoffs (451)
Legal (7264)
Lung cancer (124)
Manufacturing (98)
Maryland (380)
Massachusetts (1214)
Medical device (12945)
Medtech (12950)
Mergers & acquisitions (18364)
Metabolic disorders (287)
Michigan (120)
Minnesota (193)
Neuroscience (1353)
New Jersey (496)
New York (543)
NextGen Class of 2024 (6725)
Non-profit (4828)
North Carolina (573)
Northern California (808)
Obesity (172)
Ohio (95)
Opinion (209)
Patents (71)
Pennsylvania (474)
People (52912)
Phase I (19040)
Phase II (26922)
Phase III (20712)
Pipeline (116)
Postmarket research (2542)
Preclinical (7397)
Press Release (63)
Radiopharmaceuticals (215)
Rare diseases (135)
Real estate (5663)
Recruiting (67)
Regulatory (21336)
Research institute (2492)
Resumes & cover letters (411)
South America (1273)
Southern California (759)
Startups (3549)
Texas (208)
United States (7789)
Vaccines (563)
Washington State (229)
Weight loss (161)
Date
Last 7 days (596)
Last 30 days (2099)
Last 365 days (34902)
2024 (24608)
2023 (37836)
2022 (48494)
2021 (52905)
2020 (52613)
2019 (46515)
2018 (35737)
2017 (32331)
2016 (31338)
2015 (35415)
2014 (27071)
2013 (22253)
2012 (23986)
2011 (24759)
2010 (22068)
619,265 Results for "limflow sa".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Deals
Inari Medical Closes Acquisition of LimFlow
Inari Medical, Inc. announced the close of its acquisition of LimFlow S.A., a privately-held pioneer in limb salvage for patients with chronic limb-threatening ischemia.
November 15, 2023
·
3 min read
Deals
LimFlow Announces Agreement to Be Acquired by Inari Medical
LimFlow SA announced that it has entered into a definitive agreement to be acquired by Inari Medical, a medical device company with a mission to treat and transform the lives of patients suffering from venous and other diseases.
November 1, 2023
·
3 min read
Deals
Inari Medical Expands Its Patient-Focused Mission with Agreement to Acquire LimFlow
Inari Medical, Inc. announced that it has entered into a definitive agreement to acquire LimFlow, S.A., a privately held pioneer in limb salvage for patients with chronic limb-threatening ischemia.
November 1, 2023
·
9 min read
FDA
FDA Approves LimFlow System in Patients With Chronic Limb-Threatening Ischemia and No Suitable Endovascular or Surgical Revascularization Options
LimFlow SA announced today that the U.S. Food and Drug Administration (FDA) has approved the LimFlow System to help people with CLTI who have no other suitable endovascular or surgical treatment options and are facing major amputation.
September 12, 2023
·
5 min read
RELIEF THERAPEUTICS Holding SA Announces Results of Annual General Meeting
RELIEF THERAPEUTICS Holding SA announces the results of its annual general meeting (AGM) of shareholders, which took place in Geneva today.
June 27, 2024
·
3 min read
Landmark New England Journal of Medicine Publication Reports Positive Results From PROMISE II Pivotal Trial Showing that LimFlow System Saves Most Patients with End-stage Peripheral Artery Disease From Major Amputation
LimFlow SA announced that results from the PROMISE II U.S. pivotal trial were published.
March 30, 2023
·
6 min read
RELIEF THERAPEUTICS Holding SA Announces Results of Extraordinary General Meeting
RELIEF THERAPEUTICS Holding SA announces the results of the extraordinary general meeting of shareholders, which took place in Geneva , Friday, April 26, 2024.
April 26, 2024
·
4 min read
Business
ExcellGene SA and Cytovance Biologics Join Forces to Transform Large Molecule Biologics Development and Manufacture
ExcellGene SA proudly announces its strategic collaboration with Cytovance Biologics, a renowned Contract Development and Manufacturing Organization based in the USA.
May 8, 2024
·
3 min read
Deals
Stryker completes acquisition of SERF SAS
Stryker (NYSE: SYK), a leading global medical technology company, announced today that it has completed the previously announced acquisition of SERF SAS, a France -based joint replacement company, from Menix.
March 21, 2024
·
4 min read
Business
LimFlow Appoints Jenny Gaffney as Vice President, Health Economics and Reimbursement
LimFlow SA today announced the appointment of Jenny Gaffney as Vice President, Health Economics and Reimbursement.
August 23, 2022
·
3 min read
1 of 61,927
Next
